Stock Events

Stock Events

Curative Biotechnology 

$1.79
6
+$0.59+49.17% Friday 20:00

Statistics

Day High
0.01
Day Low
0.01
52W High
2.25
52W Low
0.01
Volume
160,391
Avg. Volume
1,573
Mkt Cap
1.92B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

9MarExpected
Q3 2011
Q4 2018
Q4 2019
Q4 2020
-0
-0
0
0
Expected EPS
N/A
Actual EPS
-0.0008

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-7.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CUBT. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen is a biotech firm that competes in the neurology space, similar to Curative Biotechnology's focus on novel therapies for serious diseases.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics in areas overlapping with Curative Biotechnology's interests.
AMGEN
AMGN
Mkt Cap160.66B
Amgen competes in the biotechnology field, focusing on human therapeutics, a sector where Curative Biotechnology is also aiming to make an impact.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is known for its work in biopharmaceuticals, directly competing with Curative Biotechnology in the development of treatments for serious medical conditions.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals operates in the biotechnology industry, focusing on creating new treatments for life-threatening diseases, similar to Curative Biotechnology's mission.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals is a direct competitor in the biopharmaceutical sector, focusing on RNAi therapeutics, a field that could overlap with Curative Biotechnology's research areas.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical competes in the biotechnology industry by focusing on enzyme replacement therapies, which could intersect with Curative Biotechnology's therapeutic areas.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk is a global healthcare company that, while primarily focused on diabetes and obesity, also explores treatments for other serious chronic diseases, potentially competing with Curative Biotechnology.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company with a broad range of products that could compete across several of Curative Biotechnology's areas of interest, including innovative therapies for serious diseases.

About

Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. The company was formerly known as Connectyx Technologies Holdings Group, Inc. and changed its name to Curative Biotechnology, Inc. in November 2020. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida.
Show more...
CEO
Mr. Paul M. Michaels
Employees
4
Country
US
ISIN
US23128N1081

Listings

OTC Link
US
CUBTD
XNYS
US
CUBT

0 Comments

Share your thoughts

FAQ

What is Curative Biotechnology stock price today?▼
The current price of CUBT is $1.79 USD — it has increased by +49.17% in the past 24 hours. Watch Curative Biotechnology stock price performance more closely on the chart.
What is Curative Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Curative Biotechnology stocks are traded under the ticker CUBT.
Is Curative Biotechnology stock price growing?▼
CUBT stock has risen by +70.48% compared to the previous week, the month change is a +86.46% rise, over the last year Curative Biotechnology has showed a +8.48% increase.
What is Curative Biotechnology market cap?▼
Today Curative Biotechnology has the market capitalization of 1.92B
What were Curative Biotechnology earnings last quarter?▼
CUBT earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Curative Biotechnology revenue for the last year?▼
Curative Biotechnology revenue for the last year amounts to 0 USD.
What is Curative Biotechnology net income for the last year?▼
CUBT net income for the last year is -7.31M USD.
How many employees does Curative Biotechnology have?▼
As of April 01, 2026, the company has 4 employees.
In which sector is Curative Biotechnology located?▼
Curative Biotechnology operates in the Health Care sector.
When did Curative Biotechnology complete a stock split?▼
The last stock split for Curative Biotechnology was on March 23, 2026 with a ratio of 1:150.
Where is Curative Biotechnology headquartered?▼
Curative Biotechnology is headquartered in Palm Beach Gardens, US.